Considerations for a combined index for limited cutaneous systemic sclerosis to support drug development and improve outcomes.
Lescoat A, Murphy SL, Roofeh D, Pauling JD, Hughes M, Sandler R, Zimmermann F, Wessel R, Townsend W, Chung L, Denton CP, Merkel PA, Steen V, Allanore Y, Del Galdo F, Godard D, Cella D, Farrington S, Buch MH, Khanna D.
Lescoat A, et al. Among authors: murphy sl.
J Scleroderma Relat Disord. 2021 Feb 1;6(1):66-76. doi: 10.1177/2397198320961967. Epub 2020 Oct 5.
J Scleroderma Relat Disord. 2021.
PMID: 34316516
Free PMC article.